|
1
|
Cairns P: Renal cell carcinoma. Cancer
Biomark. 9:461–473. 2010.
|
|
2
|
McLaughlin JK, Lipworth L and Tarone RE:
Epidemiologic aspects of renal cell carcinoma. Semin Oncol.
33:527–533. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chow WH and Devesa SS: Contemporary
epidemiology of renal cell cancer. Cancer J. 14:288–301. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rasmussen F: Metastatic renal cell cancer.
Cancer Imaging. 13:374–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu L and Belasco JG: Micro-RNA regulation
of the mammalian lin-28 gene during neuronal differentiation of
embryonal carcinoma cells. Mol Cell Biol. 25:9198–9208. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vaz C, Ahmad HM, Sharma P, et al: Analysis
of microRNA transcriptome by deep sequencing of small RNA libraries
of peripheral blood. BMC Genomics. 11:2882010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin Y, Zeng Y, Zhang F, et al:
Characterization of microRNA expression profiles and the discovery
of novel microRNAs involved in cancer during human embryonic
development. PLoS One. 8:e692302013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
|
10
|
Wang S, Huang J, Lyu H, et al: Functional
cooperation of miR-125a, miR-125b, and miR-205 in
entinostat-induced dowregulation of erbB2/erbB3 and apoptosis in
breast cancer cells. Cell Death Dis. 4:e5562013. View Article : Google Scholar
|
|
11
|
Li W, Duan R, Kooy F, et al: Germline
mutation of microRNA-125a is associated with breast cancer. J Med
Genet. 46:358–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee CH, Kuo WH, Lin CC, et al:
MicroRNA-regulated protein-protein interaction networks and their
functions in breast cancer. Int J Mol Sci. 14:11560–11606. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bi Q, Tang S, Xia L, et al: Ectopic
expression of MiR-125a inhibits the proliferation and metastasis of
hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One.
7:e401692012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karsy M, Arslan E and Moy F: Current
progress on understanding microRNAs in glioblastoma multiforme.
Genes Cancer. 3:3–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osanto S, Qin Y, Buermans HP, et al:
Genome-wide microRNA expression analysis of clear cell renal cell
carcinoma by next generation deep sequencing. PLoS One.
7:e382982012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jing Q, Huang S, Guth S, et al:
Involvement of microRNA in AU-rich element-mediated mRNA
instability. Cell. 120:623–634. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo S, Bai H, Megyola CM, et al: Complex
oncogene dependence in microRNA-125a-induced myeloproliferative
neoplasms. Proc Natl Acad Sci USA. 109:16636–16641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zaman MS, Shahryari V, Deng G, et al:
Up-regulation of microRNA-21 correlates with lower kidney cancer
survival. PLoS One. 7:e310602012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao A, Li G, Péoc’h M, Genin C and
Gigante M: Serum miR-210 as a novel biomarker for molecular
diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol.
94:115–120. 2013. View Article : Google Scholar
|
|
20
|
Slaby O, Redova M, Poprach A, et al:
Identification of MicroRNAs associated with early relapse after
nephrectomy in renal cell carcinoma patients. Genes Chromosomes
Cancer. 51:707–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Redova M, Poprach A, Nekvindova J, et al:
Circulating miR-378 and miR-451 in serum are potential biomarkers
for renal cell carcinoma. J Transl Med. 10:552012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khella HW, Bakhet M, Allo G, et al:
miR-192, miR-194 and miR-215: a convergent microRNA network
suppressing tumor progression in renal cell carcinoma.
Carcinogenesis. 34:2231–2239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murata K, Furu M, Yoshitomi H, et al:
Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p
as plasma biomarkers for rheumatoid arthritis. PLoS One.
8:e691182013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coppola N, Potenza N, Pisaturo M, et al:
Liver microRNA hsa-miR-125a-5p in HBV chronic infection:
correlation with HBV replication and disease progression. PLoS One.
8:e653362013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishida N, Mimori K, Fabbri M, et al:
MicroRNA-125a-5p is an independent prognostic factor in gastric
cancer and inhibits the proliferation of human gastric cancer cells
in combination with trastuzumab. Clin Cancer Res. 17:2725–2733.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hashiguchi Y, Nishida N, Mimori K, et al:
Down-regulation of miR-125a-3p in human gastric cancer and its
clinicopathological significance. Int J Oncol. 40:1477–1482.
2012.PubMed/NCBI
|
|
27
|
Pazo Cid RA and Antón A: Advanced
HER2-positive gastric cancer: current and future targeted
therapies. Crit Rev Oncol Hematol. 85:350–362. 2013. View Article : Google Scholar
|
|
28
|
Smith MB, Reardon J and Olson EM:
Pertuzumab for the treatment of patients with previously untreated
HER2-positive metastatic breast cancer. Drugs Today (Barc).
48:713–722. 2012.
|
|
29
|
Sendur MA, Aksoy S and Altundag K:
Pertuzumab in HER2-positive breast cancer. Curr Med Res Opin.
28:1709–1716. 2012. View Article : Google Scholar : PubMed/NCBI
|
